Makers of Wegovy & Zepbound Cut Prices for Those Without Insurance

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on March 7, 2025.

By I. Edwards HealthDay Reporter

FRIDAY, March 7, 2025 -- The makers of two popular weight-loss drugs — Wegovy and Zepbound — are cutting prices to make the medications more affordable for people without insurance.

Novo Nordisk, the Danish company behind Wegovy, announced Wednesday that it has lowered its monthly cost by 23%. The new price -- $499 per month -- takes effect immediately. It had been $650 a month.

The discount applies to all dose levels of the medication, NBC News reported.

The lower price is available to both uninsured patients and people whose insurance does not cover weight-loss drugs, the company also said.

Last week, Eli Lilly, the maker of Zepbound, also cut prices for its starter dose to $349 per month.

Larger doses will now cost $499 per month through the company's self-pay program.

People using these GLP-1 meds start with smaller doses and gradually increase to higher amounts over time.

The price cuts come as supply issues ease. Both medications have recently been removed from the U.S. Food and Drug Administration's shortage list, allowing the companies to meet growing demand.

As a result, compounding pharmacies, which were allowed to make off-brand versions during the shortage, will need to wind down production.

Both Wegovy and Zepbound belong to a class of drugs that have been shown to help people lose weight by reducing appetite and increasing the feelings of fullness.

Sources

  • NBC News, March 5, 2025

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2025-03-08 06:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords